Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia
Go back to Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia| PACIRA (NASDAQ: PCRX) | Delayed: 25.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.87 | 52 Week High | $80.25 | |||
| Open | $25.87 | 52 Week Low | $30.25 | |||
| Day High | $25.87 | P/E | N/A | |||
| Day Low | $25.87 | EPS | $-2.08 | |||
| Volume | 2,433 | |||||

